Edwin Moses - invited speaker sdAb 2025
Biography
Serial entrepreneur and value creator in European life science companies. As CEO, built two businesses (Oxford Asymmetry International plc and Ablynx nv), led their successful IPOs on the LSE, EuroNext and NASDAQ and raised over €500M in equity and debt financing. Was responsible for developing the business plans and implementing them. Ran the sales process for each company generating values of £316M and €3.9Bn respectively. Expertise in high value service provision to the pharmaceutical industry and in drug discovery and development. At Ablynx, oversaw the whole process from discovery to approval and preparation for the launch of Cablivi™ - a product designed to treat an ultra-rare hematological disease. Primarily focussed on high growth businesses and change management. 30+ years of Board level experience in more than 20 companies, mostly as Chairman. Currently mainly focussed on a small, high quality portfolio of Chairman/NED roles in both public and private life science companies with potentially breakthrough products/technologies, supporting the Board/management/company successfully undergo transformational changes. Been closely involved in raising more than €500M in equity and debt financing over the last 5 years with his current companies having raised ~€130M in 2024.